Hap Trading, LLC Concert Pharmaceuticals, Inc. Transaction History
Hap Trading, LLC
- $872 Billion
- Q3 2024
A detailed history of Hap Trading, LLC transactions in Concert Pharmaceuticals, Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 43,000 shares of CNCE stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,000Holding current value
$0% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CNCE
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About CONCERT PHARMACEUTICALS, INC.
- Ticker CNCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,934,600
- Description
- Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...